Table 5.
GO and KEGG pathway analysis for differentially expressed genes with SNPs and putative miRNA targets
Term | P-value | Benjamini |
---|---|---|
GO molecular function | ||
GO:0004672 ~ protein kinase activity | 1.61E–10 | 1.52E–07 |
GO:0004713 ~ protein tyrosine kinase activity | 1.71E–07 | 8.10E–05 |
GO:0001883 ~ purine nucleoside binding | 2.99E–07 | 9.43E–05 |
GO:0030554 ~ adenyl nucleotide binding | 4.05E–07 | 9.57E–05 |
GO:0001882 ~ nucleoside binding | 4.37E–07 | 8.26E–05 |
GO biological process | ||
GO:0006796 ~ phosphate metabolic process | 6.73E–12 | 2.30E–08 |
GO:0006793 ~ phosphorus metabolic process | 6.73E–12 | 2.30E–08 |
GO:0042127 ~ regulation of cell proliferation | 1.12E–09 | 1.91E–06 |
GO:0022403 ~ cell cycle phase | 4.51E–09 | 5.14E–06 |
GO:0009725 ~ response to hormone stimulus | 5.94E–09 | 5.08E–06 |
GO cellular component | ||
GO:0031012 ~ extracellular matrix | 5.41E–06 | 0.002361673 |
GO:0000793 ~ condensed chromosome | 8.42E–06 | 0.001838134 |
GO:0005604 ~ basement membrane | 1.32E–05 | 0.00192431 |
GO:0005578 ~ proteinaceous extracellular matrix | 1.70E–05 | 0.001851468 |
GO:0005829 ~ cytosol | 7.08E–05 | 0.006167834 |
KEGG pathway | ||
hsa05200:Pathways in cancer | 5.53E–13 | 1.00E–10 |
hsa04110:Cell cycle | 8.05E–05 | 0.007254812 |
hsa05222:Small-cell lung cancer | 8.89E–05 | 0.005350669 |
hsa00330:Arginine and proline metabolism | 0.001255698 | 0.055269935 |
hsa04510:Focal adhesion | 0.001294948 | 0.045824355 |
Abbreviations: GO, gene ontology; miRNA, microRNA; SNP, single-nucleotide polymorphism. Only top five terms in each category are shown.